The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB),
including but not limited to those available through the PAAB Forum, the PAAB website, and any PAAB
correspondences, are specifically intended to assist individuals navigating the PAAB preclearance system.
Repurposing or reproducing this content without written consent from the PAAB Commissioner is strictly
prohibited. This prohibition includes, but is not limited to, use in machine learning or AI models.
PAAB Forum Quarterly Review - Q3/2022
Blogs
1
Posts
1
Posters
594
Views
1
Watching
-
Good Afternoon @Manufacturer and @Agency
Summer has wrapped up and ARO is in full swing. Thank you to all our clients for all the great feedback and support as we launched this new service. Click here to see a round up of our Q3 activities.